Skip to content

Envoy Medical COCH Change In Fair Value Of Private Warrant Liability

Change In Fair Value Of Private Warrant Liability at other companies

Porch Group, Inc. logo
Porch Group, Inc.PRCH
$0-100%
Evolv Technologies Holdings, Inc. logo
Evolv Technologies Holdings, Inc.EVLV
-$2.04M-18.8%
Evolv Technologies Holdings, Inc. logo
Evolv Technologies Holdings, Inc.EVLV
-$2.04M-18.8%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$0+100%
FuboTV
 logo
FuboTV FUBO
$0
CuriosityStream logo
CuriosityStreamCURI
$0+100%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept coch:ChangeInFairValueOfPrivateWarrantLiability.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's change in fair value of private warrant liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's change in fair value of private warrant liability?
Envoy Medical (COCH) reported change in fair value of private warrant liability of -$2.01M in Q1 2026.
What does change in fair value of private warrant liability mean?
The non-cash gain or loss recognized due to fluctuations in the fair market value of private warrant liabilities. Because these instruments are often marked-to-market, this metric reflects volatility in the company's valuation and market-based assumptions rather than operational performance.